Adebrelimab Infusion Plus Standard Care for Pancreatic Cancer With Pleural or Peritoneal Effusions
Clinical trial NCT07230301 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07230301
- Sponsor
- Sizhen Wang
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-30
- Primary completion
- 2027-06-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.